Hereditary hemochromatosis
- PMID:23418762
Hereditary hemochromatosis
Abstract
Hereditary hemochromatosis is an autosomal recessive disorder that disrupts the body's regulation of iron. It is the most common genetic disease in whites. Men have a 24-fold increased rate of iron-overload disease compared with women. Persons who are homozygous for the HFE gene mutation C282Y comprise 85 to 90 percent of phenotypically affected persons. End-organ damage or clinical manifestations of hereditary hemochromatosis occur in approximately 10 percent of persons homozygous for C282Y. Symptoms of hereditary hemochromatosis are nonspecific and typically absent in the early stages. If present, symptoms may include weakness, lethargy, arthralgias, and impotence. Later manifestations include arthralgias, osteoporosis, cirrhosis, hepatocellular cancer, cardiomyopathy, dysrhythmia, diabetes mellitus, and hypogonadism. Diagnosis requires confirmation of increased serum ferritin levels and transferrin saturation, with or without symptoms. Subtyping is based on genotypic expression. Serum ferritin measurement is the most useful prognostic indicator of disease severity. Liver biopsy is performed to stage the degree of fibrosis with severe ferritin elevation or transaminitis, or to diagnose nonclassical hereditary hemochromatosis in patients with other genetic defects. Treatment of hereditary hemochromatosis requires phlebotomy, and the frequency is guided by serial measurements of serum ferritin levels and transferrin saturation. Iron avidity can result from overtreatment. If iron avidity is not suspected, it may mimic undertreatment with persistently elevated transferrin saturation. Dietary modification is generally unnecessary. Universal screening for hereditary hemochromatosis is not recommended, but testing should be performed in first-degree relatives of patients with classical HFE-related hemochromatosis, those with evidence of active liver disease, and patients with abnormal iron study results. Screening for hepatocellular carcinoma is reserved for those with hereditary hemochromatosis and cirrhosis.
Similar articles
- [Molecular genetic diagnostics and screening of hereditary hemochromatosis].Zlocha J, Kovács L, Pozgayová S, Kupcová V, Durínová S.Zlocha J, et al.Vnitr Lek. 2006 Jun;52(6):602-8.Vnitr Lek. 2006.PMID:16871764Slovak.
- Hemochromatosis and iron-overload screening in a racially diverse population.Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators.Adams PC, et al.N Engl J Med. 2005 Apr 28;352(17):1769-78. doi: 10.1056/NEJMoa041534.N Engl J Med. 2005.PMID:15858186
- A population-based study of the clinical expression of the hemochromatosis gene.Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW.Olynyk JK, et al.N Engl J Med. 1999 Sep 2;341(10):718-24. doi: 10.1056/NEJM199909023411002.N Engl J Med. 1999.PMID:10471457
- [Hereditary hemochromatosis].Dantas W.Dantas W.Rev Gastroenterol Peru. 2001 Jan-Mar;21(1):42-55.Rev Gastroenterol Peru. 2001.PMID:12170286Review.Portuguese.
- Recent advances in hereditary hemochromatosis.Franchini M, Veneri D.Franchini M, et al.Ann Hematol. 2005 Jun;84(6):347-52. doi: 10.1007/s00277-005-1006-8. Epub 2005 Mar 4.Ann Hematol. 2005.PMID:15747119Review.
Cited by
- Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis.Yamauchi R, Takata K, Shinagawa Y, Tanaka T, Fukuda H, Fukuda S, Kunimoto H, Umeda K, Morihara D, Yokoyama K, Takeyama Y, Irie M, Shakado S, Mizoguchi M, Hisano S, Yoshimitsu K, Sakisaka S.Yamauchi R, et al.Intern Med. 2019 Mar 1;58(5):661-665. doi: 10.2169/internalmedicine.0973-18. Epub 2018 Nov 19.Intern Med. 2019.PMID:30449774Free PMC article.
- Movement Disorders and Hematologic Diseases.Patel RA, Hall DA, Eichenseer S, Bailey M.Patel RA, et al.Mov Disord Clin Pract. 2020 Dec 29;8(2):193-207. doi: 10.1002/mdc3.13129. eCollection 2021 Feb.Mov Disord Clin Pract. 2020.PMID:33553488Free PMC article.Review.
- Genetic variant coding for iron regulatory protein HFE contributes to hypertension, the TAMRISK study.Määttä KM, Nikkari ST, Kunnas TA.Määttä KM, et al.Medicine (Baltimore). 2015 Jan;94(4):e464. doi: 10.1097/MD.0000000000000464.Medicine (Baltimore). 2015.PMID:25634189Free PMC article.
- Infiltrative Cardiomyopathies.Bejar D, Colombo PC, Latif F, Yuzefpolskaya M.Bejar D, et al.Clin Med Insights Cardiol. 2015 Jul 8;9(Suppl 2):29-38. doi: 10.4137/CMC.S19706. eCollection 2015.Clin Med Insights Cardiol. 2015.PMID:26244036Free PMC article.Review.
- A Rare Case of Aeromonas Hydrophila Infection in a Patient With Hereditary Hemochromatosis.Obeidat AE, Wong LL, Fujii-Lau L.Obeidat AE, et al.Cureus. 2021 Dec 22;13(12):e20612. doi: 10.7759/cureus.20612. eCollection 2021 Dec.Cureus. 2021.PMID:35103188Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical